Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
No IGF-1 or glucose disruption: Unlike HGH, AOD-9604 does not significantly increase IGF-1 or negatively affect insulin sensitivity, making it a safer candidate for metabolic regulation Benefits of AOD-9604 When dosed consistently, AOD-9604 provides targeted fat-burning and metabolic support without the systemic hormonal risks seen with full-length HGH
Pentadecapeptide BPC 157, in clinical trials as a therapy for inflammatory bowel disease (PL14736), is effective in the healing of colocutaneous fistulas in rats
By purchasing from our website, customers confirm that they are qualified researchers, laboratories, or research institutions and fully understand the research-use-only designation associated with these products
Delta-sleep inducing peptide and neuronal activity after glutamate microiontophoresis: the role of NMDA-receptors
It is designed as a once-weekly injectable treatment for obesity, working via amylin receptors rather than the GLP-1 pathway used by most current weight loss medications
US$ 22.22
US$ 27.02
US$ 28.22
US$ 25.21
